The long noncoding RNA MALAT1 suppresses miR‐211 to confer protection from ultraviolet‐mediated DNA damage in vitiligo epidermis by upregulating sirtuin 1

Author(s):  
H.D. Brahmbhatt ◽  
R. Gupta ◽  
A. Gupta ◽  
S. Rastogi ◽  
R. Misri ◽  
...  
Oncotarget ◽  
2017 ◽  
Vol 8 (16) ◽  
pp. 25942-25954 ◽  
Author(s):  
Cecelia R. Miller ◽  
Amy S. Ruppert ◽  
Sydney Fobare ◽  
Timothy L. Chen ◽  
Chaomei Liu ◽  
...  

Author(s):  
A. Schmitt ◽  
T. Hung ◽  
R. Flynn ◽  
A. Payumo ◽  
A. Peres-da-Silva ◽  
...  

BioFactors ◽  
2019 ◽  
Vol 46 (3) ◽  
pp. 487-496
Author(s):  
Yingjie Ding ◽  
Jing Wang ◽  
Hongliang Zhang ◽  
Huanting Li

2019 ◽  
Vol 105 (1) ◽  
pp. S163-S164
Author(s):  
E.S. Anderson ◽  
C. Marney ◽  
M. Adnan ◽  
K.L. Peng ◽  
N. Weinhold ◽  
...  

2020 ◽  
Vol 94 (12) ◽  
Author(s):  
Surendra Sharma ◽  
Karl Munger

ABSTRACT Human papillomavirus 16 (HPV16) E7 has long been known to stabilize the tumor suppressor TP53. However, the molecular mechanism of TP53 stabilization by HPV16 E7 has remained obscure, and this stabilization can occur independently of the E2F-regulated MDM2 inhibitor p14ARF. Here, we report that the damage-induced noncoding (DINO) lncRNA (DINOL) is the “missing link” between HPV16 E7 and increased TP53 levels. DINO levels are decreased in cells where TP53 is inactivated, either by HPV16 E6, by expression of a dominant negative TP53 minigene, or by TP53 depletion. DINO levels are increased in HPV16 E7-expressing cells. HPV16 E7 causes increased DINO expression independently of RB1 degradation and E2F1 activation. Similar to what is seen with the adjacent CDKN1A locus, DINO expression is regulated by the histone demethylase KDM6A. DINO stabilizes TP53 in HPV16 E7-expressing cells, and as it is a TP53 transcriptional target, DINO levels further increase. As with expression of other oncogenes, such as adenovirus E1A or MYC, HPV16 E7-expressing cells are sensitized to cell death under conditions of metabolic stress, which in the case of E7 has been linked to TP53 activation. Consistent with earlier studies, we show that HPV16 E7-expressing keratinocytes are highly sensitive to metabolic stress induced by starvation or the antidiabetic drug metformin. Sensitivity of HPV16 E7-expressing cells to metabolic stress is rescued by DINO depletion. Moreover, DINO depletion decreases sensitivity to the DNA damage-inducing chemotherapy agent doxorubicin. This work identifies DINO as a critical mediator of TP53 stabilization and activation in HPV16 E7-expressing cells. IMPORTANCE Viral oncoproteins, including HPV16 E6 and E7, have been instrumental in elucidating the activities of cellular signaling networks, including those governed by the TP53 tumor suppressor. Our study demonstrates that the long noncoding RNA DINO is the long-sought missing link between HPV16 E7 and elevated TP53 levels. Importantly, the TP53-stabilizing DINO plays a critical role in the cell death response of HPV16 E7-expressing cells to metabolic stress or DNA damage.


2020 ◽  
Vol 36 (5) ◽  
pp. 493-507 ◽  
Author(s):  
Ruixue Liu ◽  
Qingtong Zhang ◽  
Liping Shen ◽  
Shuangjing Chen ◽  
Junyan He ◽  
...  

2020 ◽  
Vol 295 (11) ◽  
pp. 3485-3496 ◽  
Author(s):  
Ilaria Caon ◽  
Barbara Bartolini ◽  
Paola Moretto ◽  
Arianna Parnigoni ◽  
Elena Caravà ◽  
...  

Hyaluronan (HA) is one of the most prevalent glycosaminoglycans of the vascular extracellular matrix (ECM). Abnormal HA accumulation within blood vessel walls is associated with tissue inflammation and is prominent in most vascular pathological conditions such as atherosclerosis and restenosis. Hyaluronan synthase 2 (HAS2) is the main hyaluronan synthase enzyme involved in HA synthesis and uses cytosolic UDP-glucuronic acid and UDP-GlcNAc as substrates. The synthesis of UDP-glucuronic acid can alter the NAD+/NADH ratio via the enzyme UDP-glucose dehydrogenase, which oxidizes the alcohol group at C6 to the COO− group. Here, we show that HAS2 expression can be modulated by sirtuin 1 (SIRT1), the master metabolic sensor of the cell, belonging to the class of NAD+-dependent deacetylases. Our results revealed the following. 1) Treatments of human aortic smooth muscle cells (AoSMCs) with SIRT1 activators (SRT1720 and resveratrol) inhibit both HAS2 expression and accumulation of pericellular HA coats. 2) Tumor necrosis factor α (TNFα) induced HA-mediated monocyte adhesion and AoSMC migration, whereas SIRT1 activation prevented immune cell recruitment and cell motility by reducing the expression levels of the receptor for HA-mediated motility, RHAMM, and the HA-binding protein TNF-stimulated gene 6 protein (TSG6). 3) SIRT1 activation prevented nuclear translocation of NF-κB (p65), which, in turn, reduced the levels of HAS2–AS1, a long-noncoding RNA that epigenetically controls HAS2 mRNA expression. In conclusion, we demonstrate that both HAS2 expression and HA accumulation by AoSMCs are down-regulated by the metabolic sensor SIRT1.


Sign in / Sign up

Export Citation Format

Share Document